A detailed history of Versant Capital Management, Inc transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Versant Capital Management, Inc holds 4,579 shares of TEVA stock, worth $76,011. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,579
Previous 5,297 13.55%
Holding current value
$76,011
Previous $81,000 6.17%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 07, 2025

SELL
$12.82 - $18.15 $9,204 - $13,031
-718 Reduced 13.55%
4,579 $76,000
Q1 2025

Apr 03, 2025

BUY
$14.67 - $22.01 $63,257 - $94,907
4,312 Added 437.77%
5,297 $81,000
Q4 2024

Jan 02, 2025

BUY
$16.43 - $22.77 $12,486 - $17,305
760 Added 337.78%
985 $21,000
Q3 2024

Oct 07, 2024

BUY
$15.81 - $18.96 $3,557 - $4,266
225 New
225 $4,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $18.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Versant Capital Management, Inc Portfolio

Follow Versant Capital Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Versant Capital Management, Inc with notifications on news.